The angiotensin II type 1 receptor antagonist (angio-tensin receptor blocker [ARB]) losartan has been shown in the LIFE (Losartan Intervention for Endpoint Reduction in Hypertension) study to ...

One of the first trials to look at this problem was the Evaluation of Losartan in the Elderly (ELITE)-I study. [43] In this randomized trial, 722 patients with heart failure were assigned to ...